Cargando…
Inhibition of MEK signaling prevents SARS-CoV2-induced lung damage and improves survival of infected mice
Coronavirus disease 2019 (COVID-19) is the illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 500 million confirmed cases of COVID-19 have been recorded, with 6 million deaths. Thus, reducing the COVID-19-related medical burden is an unmet need. Despite a vaccine th...
Autores principales: | Xie, Jingwu, Klemsz, Michael J., Kacena, Melissa A., Sandusky, George, Zhang, Xiaoli, Kaplan, Mark H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538266/ https://www.ncbi.nlm.nih.gov/pubmed/36030555 http://dx.doi.org/10.1002/jmv.28094 |
Ejemplares similares
-
Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
por: Gu, Dongsheng, et al.
Publicado: (2018) -
Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways
por: Shen, Ming-Yi, et al.
Publicado: (2012) -
IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas
por: Wang, Qing, et al.
Publicado: (2020) -
Cisplatin inhibits MEK1/2
por: Yamamoto, Tetsu, et al.
Publicado: (2015) -
SARS-CoV-2 from COVID-19 Patients in the Republic of Moldova: Whole-Genome Sequencing Results
por: Morozov, Alexandr, et al.
Publicado: (2022)